| Source HCPCS Code |
|
Target NDC Code |
J9353
Inj, margetuximab-cmkb, 5 mg
|
⇄
|
74527-0022-01
MARGENZA 250 MG/10 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9353
INJECTION, MARGETUXIMAB-CMKB, 5 MG
|
⇄
|
74527-0022-02
MARGENZA (SDV,PF) 25 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
07/01/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
CT |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9353
INJECTION, MARGETUXIMAB-CMKB, 5 MG
|
⇄
|
74527-0022-03
MARGENZA (SDV,PF) 25 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
07/01/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
CT |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9353
Inj. margetuximab-cmkb, 5 mg
|
⇄
|
74527-0022-02
Margenza
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9353
Inj. margetuximab-cmkb, 5 mg
|
⇄
|
74527-0022-03
Margenza
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|